TNF and depressive disorder: Like stressors, which may engender features of depressive disorder in rodents, the systemic administration of proinflammatory cytokines such as interleukin-1β (IL-1β) and tumor-necrosis factor-α (TNF-α) increases hypothalamic-pituitary-adrenal (HPA) activity [1, 2].